Bateman, D NicholasDear, James WThanacoody, H K RubenThomas, Simon H LEddleston, MichaelSandilands, Euan ACoyle, JudyCooper, Jamie GRodriguez, AryellyButcher, IsabellaLewis, Steff CVliegenthart, A D BastiaanVeiraiah, AravindanWebb, David JGray, Alasdair2014-12-232014-12-232014-02-22Bateman, D N, Dear, J W, Thanacoody, H K R, Thomas, S H L, Eddleston, M, Sandilands, E A, Coyle, J, Cooper, J G, Rodriguez, A, Butcher, I, Lewis, S C, Vliegenthart, A D B, Veiraiah, A, Webb, D J & Gray, A 2014, 'Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial', The Lancet, vol. 383, no. 9918, pp. 697-704. https://doi.org/10.1016/S0140-6736(13)62062-00140-6736ORCID: /0000-0003-3812-7026/work/188766610http://hdl.handle.net/2164/4126Acknowledgments We thank our colleagues in the treating hospitals who assisted with recruitment and patients’ management, the Data Monitoring Committee (R E Ferner, J E Gray, and K Simpson), and the programmers in the Edinburgh Clinical Trials Unit. The trial was funded by Chief Scientist Office, Scotland (award CZB/4/722).8415339engAcetaminophenAcetylcysteineAdultAgedAlanine TransaminaseAntiemeticsDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationFemaleGreat BritainHumansInfusions, IntravenousLiver Failure, AcuteMaleMiddle AgedNauseaOndansetronPoisoningTreatment OutcomeVomitingR Medicine (General)R1Journal article10.1016/S0140-6736(13)62062-0